|Page (1) of 1 - 05/23/14||email article||print page|
Astrazeneca is off its 52 week high after rebuffing offers from Pfizer this month. In its final proposal announcement, Pfizer announced a possible offer comprising, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.001. Shares of AZN are trading at $72.67 this morning versus a 52 week high of $82.68.
|New Options For Trading Astrazeneca|
Source:GrabNetworks (c). All Rights Reserved